Contraceptives Market (Drugs, Devices, Pills, Hormonal & Copper IUDs, Vaginal Rings, Subdermal Implants, Topical Contraceptives, Injectables, Diaphragms, Sponges, Male & Female Condoms) - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 -
NEW YORK, May 22, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Contraceptives Market (Drugs, Devices, Pills, Hormonal & Copper IUDs, Vaginal Rings, Subdermal Implants, Topical Contraceptives, Injectables, Diaphragms, Sponges, Male & Female Condoms) - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 -
Contraceptives Market (Drugs, Devices, Pills, Hormonal & Copper IUDs, Vaginal Rings, Subdermal Implants, Topical Contraceptives, Injectables, Diaphragms, Sponges, Male & Female Condoms) - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018 Contraceptive drugs and devices are temporary birth control methods and function majorly by altering the mechanism of ovulation and acting as physical barriers between the sperm and ovary. This report holds the market estimation of the global contraceptives market in terms of value (USD million) for the period 2012 – 2018, considering the base year 2011 as. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contraceptives market. The overall contraceptives market is categorized on the basis of products into two major categories namely contraceptive drugs and contraceptive devices. The contraceptive drugs market is further sub-segmented into contraceptive pills, injectables and contraceptive sponges and the contraceptive devices market is sub-segmented into male and female contraceptive devices. The male contraceptive devices consist of male condoms and the female contraceptive devices consist of female condoms, diaphragms, sponges, vaginal rings, subdermal contraceptive implants and intra uterine devices (copper and hormonal). The market for all these segments and sub-segments is estimated for the period 2012 – 2018 in terms of value (USD million). The market is also forecasted in terms of value (USD million) for the period 2012 – 2018 for four major geographic regions namely North America, Asia-Pacific, Europe and the rest of the world. Some of the key market players of the global contraceptives market include Merck, Bayer HealthCare, Church & Dwight, Warner Chilcott Company, Inc., Pfizer, Agile Therapeutics, Biosante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience and Teva Pharmaceuticals. Market players are profiled in this report on the basis of parameters such as company overview, business strategies adopted by the companies to ensure sustainability and maximize profits, financial overview and recent developments. The global contraceptive market is categorized into the following segments Contraceptives Market by Products Contraceptive Drugs Oral Contraceptive Pills Contraceptive Injectables Topical Contraceptives Contraceptive Devices Male Contraceptive Devices (Male Condoms) Female Contraceptive Devices Female Condoms Diaphragms Sponges IUDs Hormonal IUDs Copper IUDs Subdermal Contraceptive Implants Vaginal Rings Contraceptives Market by Geography North America Europe Asia-Pacific Rest of the World (RoW)
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Growing Prevalence of Unwanted Pregnancies and High Global Prevalence of Women with Unmet Contraceptive Needs
3.1.1.2 Government and NGO Initiatives to Promote Contraceptive Products
3.1.1.3 Implementation of the Patient Protection Act or the Affordable Care Act
3.1.1.4 Rising Global Prevalence of Sexually Transmitted Infections (STI)
3.1.2 Impact Analysis of Market Drivers for the Global Contraceptives Market
3.1.3 Market Restraints
3.1.3.1 Side Effects Associated with the use of Contraceptive Drugs and Devices
3.1.3.2 Rapidly Aging Population and Rising Prevalence of Infertility
3.1.4 Impact Analysis of Market Restraints for the Global Contraceptives Market
3.1.5 Market Opportunities
3.1.5.1 Presence of Strong Contraceptives Pipeline
3.1.5.1.1 Male Contraceptive Drugs
3.1.5.1.2 AG200-15 Topical Contraceptive Patch
3.1.5.1.3 FC Patch Low
3.1.5.1.4 Pill-Plus
3.1.5.1.5 Other Products in Pipeline
3.1.5.2 Presence of Large Unmet Contraceptive Needs in Emerging Asian and African Economies
3.2 Porter's Five Forces Analysis: Global Contraceptives Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
3.4 Global Contraceptives Market, 2010 – 2018 (USD Million)
Chapter 4 Global Contraceptives Market, by Products
4.1 Overview
4.2 Global Contraceptive Drugs Market
4.2.1 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
4.2.2 Global Oral Contraceptive Pills Market
4.2.2.1 Competitive Landscape: Global Oral Contraceptives Market, 2011
4.2.2.2 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
4.2.3 Global Contraceptive Injectables Market
4.2.3.1 Competitive Landscape: Global Contraceptive Injectables Market, 2011
4.2.3.2 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
4.2.4 Global Topical Contraceptives Market
4.2.4.1 Competitive Landscape: Global Topical Contraceptives Market
4.2.4.2 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
4.3 Global Contraceptive Devices Market
4.3.1 Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.1 Competitive Landscape: Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.2 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018 (USD Million)
4.3.2 Global Female Contraceptive Devices Market
4.3.2.1 Global Female Condoms Market
4.3.2.1.1 Global Female Condoms Market, 2010 – 2018 (USD Million)
4.3.2.2 Global Contraceptive Diaphragms Market
4.3.2.2.1 Global Contraceptive Diaphragms Market, 2010 – 2018 (USD Million)
4.3.2.3 Global Contraceptive Sponges Market
4.3.2.3.1 Competitive Landscape: Global Contraceptive Sponges Market
4.3.2.3.2 Global Contraceptive Sponges Market, 2010 – 2018 (USD Million)
4.3.2.4 Global Contraceptive Vaginal Rings Market
4.3.2.4.1 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD Million)
4.3.2.5 Global Intrauterine Devices (IUD) Market
4.3.2.5.1 Global Copper IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.2 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.3 Competitive Landscape: Global IUD Market, 2011
4.3.2.6 Global Sub-dermal Contraceptive Implants Market
4.3.2.6.1 Global Sub-dermal Contraceptive Implants Market, 2010 – 2018 (USD Million)
4.3.2.6.2 Competitive Landscape: Global Sub-dermal Contraceptive Implants Market
Chapter 5 Global Contraceptives Market, by Geography
5.1 Overview
5.2 North America Contraceptives Market
5.2.1 North America Contraceptives Market, 2010 – 2018 (USD Million)
5.2.2 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.3 Europe Contraceptives Market
5.3.1 Europe Contraceptives Market, 2010 – 2018 (USD Million)
5.3.2 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.4 Asia-Pacific Contraceptives Market
5.4.1 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
5.4.2 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.5 Rest of the World (RoW) Contraceptives Market
5.5.1 RoW Contraceptives Market, 2010 – 2018 (USD Million)
5.5.2 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
Chapter 6 Recommendations
6.1 Investing in Emerging Economies such as India and China and Underdeveloped African Economies
6.2 Making Rigorous R&D Initiatives
6.3 Investing in Marketing Campaigns to Elevate Customer Awareness
6.4 Tracking patent expiration of Branded Products
Chapter 7 Company Profiles
7.1 Merck & Co.
7.1.1 Company Profile
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategy
7.1.5 Recent Developments
7.2 Bayer HealthCare AG
7.2.1 Company Profile
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Church & Dwight, Co. Inc.
7.3.1 Company Profile
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategy
7.3.5 Recent Developments
7.4 Warner Chilcott Company, Inc.
7.4.1 Company Profile
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategy
7.4.5 Recent Developments
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategy
7.5.5 Recent Developments
7.6 Agile Therapeutics Inc.
7.6.1 Company Overview
7.6.2 Business Strategy
7.6.3 Product Portfolio
7.6.4 Recent Developments
7.7 BioSante Pharmaceuticals Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Business Strategy
7.7.4 Product Portfolio
7.7.5 Recent Developments
7.8 Mayer Laboratories, Inc.
7.8.1 Company Overview
7.8.2 Business Strategy
7.8.3 Product Portfolio
7.8.4 Recent Developments
7.9 Pantarhei Bioscience B.V.
7.9.1 Company Overview
7.9.2 Business Strategy
7.9.3 Product Portfolio
7.9.4 Recent Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Product Portfolio
7.10.5 Recent Developments
List of Figures
FIG. 1 Market Segmentation: Global Contraceptives Market
FIG. 2 Global Contraceptives Market, by Product Types, 2011 (USD Million)
FIG. 3 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 4 Average percentage of women with unmet contraceptive needs in the Southeast Asian, South Central Asian and Sub-Saharan African countries, 2011 (%)
FIG. 5 Porter's Five Forces Analysis: Global Contraceptives Market
FIG. 7 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
FIG. 8 Global Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 9 Comparative Analysis of the Global Contraceptives Market, by Products, 2011 & 2018 (%)
FIG. 10 Comparative Analysis of the Global Contraceptive Drugs Market, by Product Types, 2011 & 2018 (%)
FIG. 11 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
FIG. 12 Competitive Landscape by Market Players: Global Oral Contraceptives Market, 2011 (%)
FIG. 13 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
FIG. 14 Competitive Landscape, by Brands: Global Contraceptive Injectables Market, 2011
FIG. 15 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
FIG. 16 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 17 Comparative Analysis of the Global Contraceptive Devices Market, by Product Types, 2011 & 2018 (%)
FIG. 18 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018 (USD Million)
FIG. 19 Global Female Condoms Market, 2010 – 2018 (USD Million)
FIG. 20 Global Female Diaphragms Market, 2010 – 2018 (USD Million)
FIG. 21 Global Contraceptive Sponges Market, 2010 – 2018 (USD Million)
FIG. 22 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD Million)
FIG. 23 Comparative Analysis of the Global IUD Market, by Product Types, 2011 & 2018 (%)
FIG. 24 Global Copper IUD Market, 2010 – 2018 (USD Million)
FIG. 25 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
FIG. 26 Global Sub-dermal Contraceptive Implants Market, 2010 – 2018 (USD Million)
FIG. 27 Comparative Analysis of the Global Contraceptives Market by Geography, 2011 & 2018 (%)
FIG. 28 North America Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 29 Europe Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 30 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 31 RoW Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 32 Annual Revenues: Merck & Co., 2009 - 2011 (USD million)
FIG. 33 Annual Revenues: Bayer HealthCare AG., 2009 – 2011 (USD Million) (1 Euro = 1.30 USD)
FIG. 34 Annual revenues: Church & Dwight Co. Inc., 2009 – 2011 (USD Million)
FIG. 35 Annual Revenues: Warner Chilcott Co. Inc., 2009 - 2011 (USD million)
FIG. 36 Annual revenues: Pfizer Inc., 2009 – 2011 (USD Million)
FIG. 37 Annual Revenues: BioSante Pharmaceuticals Inc., 2009 – 2011 (USD Thousands)
FIG. 38 Annual Revenues: Teva Pharmaceutical Industries Ltd., 2009 – 2011 (USD Million)
List of Tables
TABLE 1 Market Snapshot: Global Contraceptives Market
TABLE 2 Impact Analysis of Market Drivers for the Global Contraceptives Market
TABLE 3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
TABLE 4 Impact Analysis of Market Restraints for the Global Contraceptives Market
TABLE 5 Contraceptive Products in Pipeline, Product Status and Manufacturer Names
TABLE 6 Global Contraceptives Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 7 Global Contraceptives Drugs Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 8 List of Latest Oral Contraceptive Pill Approvals, 2010 – 2012
TABLE 9 Global Female Contraceptive Devices Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 10 Global IUD Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 11 Global Contraceptives Market, by Geography, 2010 – 2018 (USD Million)
TABLE 12 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 13 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 14 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 15 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
To order this report:
Medical_Equipment_and_Supply Industry: Contraceptives Market (Drugs, Devices, Pills, Hormonal & Copper IUDs, Vaginal Rings, Subdermal Implants, Topical Contraceptives, Injectables, Diaphragms, Sponges, Male & Female Condoms) - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 -
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article